X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
acenocoumarol (4) 4
acenocoumarol - administration & dosage (4) 4
anticoagulants - administration & dosage (4) 4
acenocoumarol - adverse effects (3) 3
administration, oral (3) 3
anticoagulants (3) 3
health aspects (3) 3
index medicus (3) 3
international normalized ratio (3) 3
netherlands (3) 3
warfarin (3) 3
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
algorithms (2) 2
anticoagulants - adverse effects (2) 2
anticoagulants - therapeutic use (2) 2
anticoagulation (2) 2
aryl hydrocarbon hydroxylases - genetics (2) 2
biomedicine (2) 2
bleeding complications (2) 2
blood coagulation - drug effects (2) 2
cytochrome p-450 cyp2c9 (2) 2
cytochrome p4502c9 (2) 2
decision support techniques (2) 2
dosage (2) 2
dose requirement (2) 2
drug interactions (2) 2
drug therapy (2) 2
female (2) 2
hematology (2) 2
male (2) 2
medicine (2) 2
middle aged (2) 2
multidisciplinary sciences (2) 2
oral anticoagulant-therapy (2) 2
peripheral vascular disease (2) 2
pharmacology & pharmacy (2) 2
phenprocoumon - administration & dosage (2) 2
phenprocoumon - adverse effects (2) 2
polymorphism, genetic (2) 2
science (2) 2
thromboembolism (2) 2
vitamin k - antagonists & inhibitors (2) 2
acenocoumarol - pharmacokinetics (1) 1
acenocoumarol - pharmacology (1) 1
acenocoumarol - therapeutic use (1) 1
adolescent (1) 1
algorithm (1) 1
allelic variants (1) 1
antagonists (1) 1
anti-inflammatory agents, non-steroidal - administration & dosage (1) 1
anti-inflammatory agents, non-steroidal - adverse effects (1) 1
anti-inflammatory agents, non-steroidal - pharmacology (1) 1
anti-inflammatory agents, non-steroidal - therapeutic use (1) 1
anticoagulant (1) 1
anticoagulants - economics (1) 1
anticoagulants - pharmacokinetics (1) 1
antithrombins - economics (1) 1
antithrombins - therapeutic use (1) 1
arthroplasty, replacement, hip - adverse effects (1) 1
aryl hydrocarbon hydroxylases - metabolism (1) 1
association (1) 1
atrial-fibrillation (1) 1
automation (1) 1
biosimilar (1) 1
biotransformation (1) 1
bleeding (1) 1
cancer research (1) 1
cardiac arrhythmia (1) 1
cardiovascular disease (1) 1
care and treatment (1) 1
clinical trials (1) 1
coagulation monitoring (1) 1
comorbidity (1) 1
cost analysis (1) 1
cost engineering (1) 1
cost reduction (1) 1
cost savings (1) 1
cost-benefit analysis (1) 1
cost-effectiveness (1) 1
costs (1) 1
coumarins (1) 1
cyp2c9 genotypes (1) 1
cyp2c9-asterisk-3 alleles (1) 1
dabigatran (1) 1
dabigatran - economics (1) 1
dabigatran - therapeutic use (1) 1
data analysis (1) 1
data processing (1) 1
dictionaries (1) 1
diet (1) 1
dietary supplements (1) 1
direct thrombin inhibitors (1) 1
dosage and administration (1) 1
drug dosage calculations (1) 1
drug monitoring (1) 1
drug monitoring - methods (1) 1
embolisms (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS One, ISSN 1932-6203, 2019, Volume 14, Issue 5, p. e0215858
Dietary supplements are products that are widely used for instance as energisers or to lose weight. There have been cases reported where undeclared ingredients... 
MULTIDISCIPLINARY SCIENCES | Internet/Web search services | User statistics | Health aspects | Food contamination | Dietary supplements | Studies | Dictionaries | Diet | Search engines | Social networks | Environmental monitoring | Refueling
Journal Article
The Lancet, ISSN 0140-6736, 1994, Volume 343, Issue 8896, pp. 499 - 503
The use of long-term oral anticoagulant treatment after myocardial infarction remains controversial because of conflicting findings on mortality in previous... 
MEDICINE, GENERAL & INTERNAL | Evaluation | Anticoagulants (Medicine) | Drug therapy | Heart attack | Medical research | Cardiovascular disease | Mortality
Journal Article
Journal Article
Molecular Diagnosis and Therapy, ISSN 1177-1062, 01/2007, Volume 11, Issue 2, pp. 123 - 128
Objective: To determine the influence of NSAIDs on the international normalized ratio (INR) in patients with cytochrome P450 (CYP)-2C9 enzyme variants starting... 
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135054
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 12/2008, Volume 100, Issue 6, pp. 1052 - 1057
Summary Coumarin oral anticoagulant drugs have proven to be effective for the prevention of thromboembolic events. World-wide, warfarin is the most prescribed... 
Clinical trials | oral anticoagulants | pharamacogenetics | pharmacodynamics | Review Article | Pharamacogenetics | Pharmacodynamics | Oral anticoagulants | VKORC1 | ORAL ANTICOAGULANT-THERAPY | BLEEDING COMPLICATIONS | IN-VITRO | CYP2C9 GENOTYPES | GENETIC-DETERMINANTS | VITAMIN-K | CYP2C9-ASTERISK-3 ALLELES | CYTOCHROME P4502C9 | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | DOSE REQUIREMENT | Cytochrome P-450 CYP2C9 | Anticoagulants - administration & dosage | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Warfarin - adverse effects | Mixed Function Oxygenases - metabolism | Warfarin - administration & dosage | Phenprocoumon - administration & dosage | Drug Interactions | Biotransformation | Phenprocoumon - adverse effects | Phenprocoumon - pharmacokinetics | Pharmacogenetics | Risk Assessment | Administration, Oral | Acenocoumarol - pharmacokinetics | Anticoagulants - adverse effects | Vitamin K Epoxide Reductases | Aryl Hydrocarbon Hydroxylases - metabolism | Polymorphism, Genetic | Warfarin - pharmacokinetics | International Normalized Ratio | Acenocoumarol - adverse effects | Acenocoumarol - administration & dosage | Blood Coagulation - drug effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anticoagulants - pharmacokinetics | Hemorrhage - chemically induced | Drug Monitoring | Mixed Function Oxygenases - genetics
Journal Article
10/1985
The possibilities of fast and efficient production of handwriting catalogs using computers were investigated. The description scheme for codices and the... 
Report
British Journal of Clinical Pharmacology, ISSN 0306-5251, 11/2019, Volume 85, Issue 11, pp. 2479 - 2486
Biosimilars of low molecular weight heparins (LMWHs) are more alike the originator than different branded LMWHs. The latter differ largely in molecular weight,... 
low molecular weight heparin | anticoagulant | generics | formulary | biosimilar
Journal Article
Expert Review of Pharmacoeconomics & Outcomes Research, ISSN 1473-7167, 02/2007, Volume 7, Issue 1, pp. 49 - 58
This paper reviews the clinical and pharmacoeconomic studies that have been conducted within Europe for patients undergoing elective hip-replacement surgery.... 
cost-effectiveness | fondaparinux | thromboprophylaxis | total hip replacement | dabigatran | acenocoumarol | direct thrombin inhibitors | rivaroxban | Fondaparinux | Direct thrombin inhibitors | Thromboprophylaxis | Dabigatran | Total hip replacement | Cost-effectiveness | Rivaroxban | Acenocoumarol | Patient outcomes | Dosage and administration | Heparin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.